SHI Zu-xuan1, TANG Yu2, LI Ke3, et al. Effect of pregnane X receptor (PXR) expression on chemotherapeutic sensitivity to CPT-11 in colon cancer cells. [J]. Journal of Chongqing Medical University 36(11):1381-1383(2011)
SHI Zu-xuan1, TANG Yu2, LI Ke3, et al. Effect of pregnane X receptor (PXR) expression on chemotherapeutic sensitivity to CPT-11 in colon cancer cells. [J]. Journal of Chongqing Medical University 36(11):1381-1383(2011)DOI:
Effect of pregnane X receptor (PXR) expression on chemotherapeutic sensitivity to CPT-11 in colon cancer cells
Objective:To investigate the effects of PXR expression changes in human colon cancer cell on chemotherapeutic sensitivity to CPT-11.Methods:The expression levels of PXR in human colon cancer cells LS174T、HT29 and HCT116 were measured by Western blot.After upregulation or downregulation of PXR expression by rifampicin or sulforaphane
cell growth was studied by MTT assay and cell cycle was measured by flow cytometry.Results:The expression levels of PXR in LS174T cell were the highest among human colon cancer cells LS174T、HT29 and HCT116(P=0.000).After being treated with sulforaphane
PXR expression in LS174T cell was significantly down-regulated(P=0.000)and cell proliferation was suppressed after being treated with CPT-11(P=0.013)
so the chemotherapeutic sensitivity of LS174T cell to CPT-11 was significantly increased.By contrast
after being treated with rifampicin
PXR expression in LS174T cell was significantly up-regulated(P=0.000) and cell proliferation was enhanced(P=0.019)
so the chemotherapeutic sensitivity to CPT-11 was significantly decreased.Conclusion:The expression changes of PXR in human colon cancer cell have significant effect on chemotherapeutic sensitivity to CPT-11
and this mechanism may play an important role in the drug resistance mechanisms of human colon cancer.